48,868
edits
Difference between revisions of "Non-small cell lung carcinoma"
Jump to navigation
Jump to search
Non-small cell lung carcinoma (view source)
Revision as of 14:44, 29 April 2016
, 14:44, 29 April 2016→Sign out
| Line 123: | Line 123: | ||
|} | |} | ||
===Not otherwise specified=== | |||
<pre> | <pre> | ||
Lung, Left Lower Lobe, Core Biopsy: | Lung, Left Lower Lobe, Core Biopsy: | ||
| Line 137: | Line 138: | ||
The neuroendocrine markers (chromogranin A, synaptophysin, CD56) and the squamous | The neuroendocrine markers (chromogranin A, synaptophysin, CD56) and the squamous | ||
markers (p63, CK5/6) are negative; thus, the tumour is not further classified. | markers (p63, CK5/6) are negative; thus, the tumour is not further classified. | ||
</pre> | |||
===Favour squamous=== | |||
<pre> | |||
Lung, Left Upper Lobe, Core Biopsy: | |||
- NON-SMALL CELL CARCINOMA, favour squamous cell carcinoma, see comment. | |||
Comment: | |||
The tumour stains as follows: | |||
POSITIVE: AE1/AE3, CK5/6, CK7. | |||
NEGATIVE: TTF-1, napsin A, p63, CDX2, CK20, S-100. | |||
EGFR/ALK testing has been ordered. | |||
The immunostains favour squamous cell carcinoma. | |||
</pre> | </pre> | ||